Skip to main content

MESA LABORATORIES INC /CO/

For the period ended Dec 31, 2025. Filed Feb 3, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 3, 2026

MLAB$127.82-0.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

Three Months Ended December 31,Nine Months Ended December 31,
2025202420252024
Revenues$65,126$62,840$185,406$178,843
Cost of revenues23,33123,08669,34166,385
Gross profit41,79539,754116,065112,458
Operating expense:
Selling9,98610,45030,71530,415
General and administrative18,80518,47254,52652,754
Research and development5,0295,05315,06114,422
Total operating expense33,82033,975100,30297,591
Operating income7,9755,77915,76314,867
Non-operating expense (income):
Interest expense and amortization of debt issuance costs3,0362,8428,0969,340
(Gain) on extinguishment of convertible notes---(2,887)
Other expense (income), net3435,154(5,940)2,914
Total non-operating expense, net3,3797,9962,1569,367
Earnings (loss) before income taxes4,596(2,217)13,6075,500
Income tax expense (benefit)966(541)2,759360
Net income (loss)$3,630$(1,676)$10,848$5,140
Earnings (loss) per share:
Basic$0.66$(0.31)$1.97$0.95
Diluted$0.65$(0.31)$1.95$0.94
Weighted-average common shares outstanding:
Basic5,5325,4295,5045,413
Diluted5,5655,4295,5525,464
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.